Skip Navigation LinksHome > May 2010 - Volume 22 - Issue 3 > Advances in the systemic treatment of head and neck cancers
Current Opinion in Oncology:
doi: 10.1097/CCO.0b013e3283376e15
Head and neck: Edited by Ahmad Awada

Advances in the systemic treatment of head and neck cancers

Specenier, Pol; Vermorken, Jan B

Collapse Box


Purpose of review: To summarize the recent literature on the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck.

Recent findings: Multiple targeted therapies and novel combinations of chemotherapeutic agents were tested.

Summary: In a large randomized phase III trial, the addition of cetuximab to platin-based chemotherapy led to a significant prolongation of overall survival. The combination of cetuximab and platin/5-fluorouracil should be considered the current standard first-line regimen. In contrast, the results with oral tyrosine kinase inhibitors and other targeted agents have been disappointing thus far.

© 2010 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.